John M. Burke, MD from Rocky Mountain Cancer Centers discusses new conjugate CD 79 and relapsed refractory B-Cell at the 2017 American Society of Hematology.
New Conjugate CD 79 – Relapsed Refractory B-Cell
John M. Burke, MD from Rocky Mountain Cancer Centers discusses new conjugate CD 79 and relapsed refractory B-Cell at the 2017 American Society of Hematology.